51.45
price up icon0.39%   0.20
after-market Handel nachbörslich: 51.44 -0.01 -0.02%
loading

Gsk Plc Adr Aktie (GSK) Neueste Nachrichten

pulisher
Jul 14, 2026

GSK's Jemperli Delivers Promising Interim Data in Rectal Cancer - TradingView

Jul 14, 2026
pulisher
Jul 13, 2026

GSK Stock Quote Price and Forecast - CNN

Jul 13, 2026
pulisher
Jul 13, 2026

GSK reports Jemperli rectal cancer trial results - grafa.com

Jul 13, 2026
pulisher
Jul 11, 2026

GSK Adds Positive Phase 3 Lung Cancer Data, Ends Alector Partnership - Sahm

Jul 11, 2026
pulisher
Jul 10, 2026

As Biopharma Turns to China, ESG Risks and Geopolitics Remain in Focus - Morningstar

Jul 10, 2026
pulisher
Jul 06, 2026

Price to earnings forward of GSK plc Sponsored ADR – MUN:GS70 - TradingView

Jul 06, 2026
pulisher
Jul 05, 2026

GSKGSK Plc ADR Latest SEC Filings - Finviz

Jul 05, 2026
pulisher
Jun 30, 2026

Big Pharma Has a Case of Merger Mania - The Motley Fool

Jun 30, 2026
pulisher
Jun 29, 2026

GS70 Forecast — Price Target — Prediction for 2027 - TradingView

Jun 29, 2026
pulisher
Jun 29, 2026

Shareholder in GSK (NYSE: GSK) trims voting stake to 4.96% - Stock Titan

Jun 29, 2026
pulisher
Jun 29, 2026

GSK to strengthen oncology pipeline with $10.6B Nuvalent buyout - MSN

Jun 29, 2026
pulisher
Jun 27, 2026

Price to earnings forward of GSK plc Sponsored ADR – LS:A3DMHS - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

A3DMHS Forecast — Price Target — Prediction for 2027 - TradingView

Jun 27, 2026
pulisher
Jun 26, 2026

GSK plc (GSK) Stock Price, News, Quote & History - Yahoo Finance

Jun 26, 2026
pulisher
Jun 26, 2026

GSK (GSK) reports major holder crossing 5% voting rights threshold - Stock Titan

Jun 26, 2026
pulisher
Jun 25, 2026

GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs Actuals & Estimates (BCBA:GSKC) - TradingView

Jun 25, 2026
pulisher
Jun 17, 2026

Why GSK's Shingrix is reshaping the shingles vaccine market - AD HOC NEWS

Jun 17, 2026
pulisher
Jun 17, 2026

GSK PLC (GSK) Stock Price, Trades & News - GuruFocus

Jun 17, 2026
pulisher
Jun 17, 2026

GSK, Spero Win FDA Nod For First-Ever Oral Carbapenem Antibiotic For Complicated UTIs - Sahm

Jun 17, 2026
pulisher
Jun 16, 2026

Here's Our Take On Theravance Biopharma Inc (NASDAQ:TBPH) and GlaxoSmithKline plc (ADR) (NYSE:GSK)'s Latest Submission - Yahoo Finance

Jun 16, 2026
pulisher
Jun 12, 2026

GSK's Momelotinib Gets Orphan Tag for Rare Hemato-Inflammatory Disorder - TradingView

Jun 12, 2026
pulisher
Jun 11, 2026

Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal - Sahm

Jun 11, 2026
pulisher
Jun 10, 2026

GSK Makes Its Biggest Bet In More Than A Decade, Paying $10.6 Billion For Cancer Drug Developer Nuvalent - Sahm

Jun 10, 2026
pulisher
Jun 10, 2026

GSK plc stock (GB0009252882): Nuvalent deal sharpens oncology focus - AD HOC NEWS

Jun 10, 2026
pulisher
Jun 09, 2026

GSK to Strengthen Oncology Pipeline With $10.6B Nuvalent Buyout - TradingView

Jun 09, 2026
pulisher
Jun 09, 2026

GSK to acquire cancer biotech Nuvalent in $10.6 billion deal - grafa.com

Jun 09, 2026
pulisher
Jun 06, 2026

Why is Glaxo (GSK) down 2.1% since last earnings report? - MSN

Jun 06, 2026
pulisher
Jun 03, 2026

GSK Bets on Specialty Medicines to Drive Long-Term Revenue Growth - TradingView

Jun 03, 2026
pulisher
Jun 02, 2026

GSK plc (ADR) stock (GB0009252882): ADR treads water around mid-USD 50s as London shares retreat on - Ad-hoc-news.de

Jun 02, 2026
pulisher
Jun 01, 2026

GSK plc (ADR) stock (GB0009252882): ADR holds steady as investors await next catalysts after recent - AD HOC NEWS

Jun 01, 2026
pulisher
May 29, 2026

GSK Stock Price, Quote & Chart | GSK PLC-SPON ADR (NYSE:GSK) - ChartMill

May 29, 2026
pulisher
May 27, 2026

GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs Revenue Breakdown – BCBA:GSK.CI - TradingView

May 27, 2026
pulisher
May 27, 2026

GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs Earnings and Revenue – BCBA:GSK.CI - TradingView

May 27, 2026
pulisher
May 27, 2026

GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs Balance Sheet – BCBA:GSK.CI - TradingView

May 27, 2026
PFE PFE
$24.82
price up icon 2.35%
$131.70
price up icon 1.28%
$358.32
price up icon 0.86%
NVO NVO
$50.56
price up icon 3.04%
AZN AZN
$168.37
price up icon 2.35%
NVS NVS
$150.80
price up icon 0.29%
Kapitalisierung:     |  Volumen (24h):